Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Pieris Pharmaceuticals Progresses in HER2 Gastric Cancer Development with Phase 2 Advancements

Pieris Pharmaceuticals Progresses in HER2 Gastric Cancer Development with Phase 2 Advancements

Pieris Pharmaceuticals (ISIN: US72016P1057) is garnering attention as its lead candidate, Cinrebafusp alfa, advances into phase 2 trials for HER2-positive gastric cancer, indicating potential progress in immunotherapy. Investors, particularly from…

Read more about the article New Research Position Announced at NIPER for Pharmaceutical Professionals

New Research Position Announced at NIPER for Pharmaceutical Professionals

The National Institute of Pharmaceutical Education and Research (NIPER) has announced a new opportunity for professionals in the pharmaceutical sciences. Recognised as the first national-level institute in this field, NIPER…

Read more about the article Unveiling Abyssal Biotech: New Flatworm Species Discovered in the Deep Sea

Unveiling Abyssal Biotech: New Flatworm Species Discovered in the Deep Sea

Tokyo – A recent discovery of novel flatworms thriving at a remarkable depth of 6,200 meters beneath the Pacific Ocean marks a significant advancement in marine biology. This finding not…

Read more about the article Cytotheryx Acquires Rochester Facilities for $7.6 Million

Cytotheryx Acquires Rochester Facilities for $7.6 Million

ROCHESTER — Cytotheryx, an emerging biotechnology company focused on developing treatments for liver disease, has recently completed the acquisition of the two Rochester facilities it currently occupies for a total…

Read more about the article Zydus Introduces Innovative Multi-Dose Pen for Semaglutide Injection in India

Zydus Introduces Innovative Multi-Dose Pen for Semaglutide Injection in India

Ahmedabad, Gujarat, India – Business Wire India Zydus Lifesciences Limited, a global leader in innovation within the life sciences sector, has launched Semaglutide Injection in India, marketed under the brand…

Read more about the article Aelis Farma Initiates Recruitment for Clinical Trial on Drug for Down Syndrome

Aelis Farma Initiates Recruitment for Clinical Trial on Drug for Down Syndrome

BORDEAUX, France - Aelis Farma (Euronext Paris: AELIS) has officially commenced recruitment for its Phase 2B clinical trial evaluating AEF0217 in patients diagnosed with Down syndrome. This initiative spans France,…

Read more about the article China Approves Commercial Brain Chips, Outpacing Western Trials

China Approves Commercial Brain Chips, Outpacing Western Trials

The National Medical Products Administration of China has granted approval for the sale of the country's first commercial brain chips, allowing direct sales to patients. This significant development positions China…

Read more about the article Celebrating Kiran Mazumdar-Shaw: A Pioneer in Biotechnology

Celebrating Kiran Mazumdar-Shaw: A Pioneer in Biotechnology

Kiran Mazumdar-Shaw, born on 23 March 1953, stands as a pioneering figure in India's biotechnology sector and is recognised as one of the nation's most influential business leaders. As the…

Read more about the article Novartis to Acquire Promising Breast Cancer Drug in Up to $3 Billion Agreement

Novartis to Acquire Promising Breast Cancer Drug in Up to $3 Billion Agreement

Swiss pharmaceutical company Novartis has announced an agreement to acquire a breast cancer drug candidate from U.S. biotech firm Synnovation Therapeutics for a total of up to $3 billion. This…

Read more about the article Cathy Tie Establishes Origin Genomics to Promote Responsible Germline Gene Correction in the United States

Cathy Tie Establishes Origin Genomics to Promote Responsible Germline Gene Correction in the United States

NEW YORK--(BUSINESS WIRE)--Cathy Tie, a serial entrepreneur in the biotech sector, has officially announced the founding of Origin Genomics, a company located in New York aimed at enhancing precision in…

  • Go to the previous page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • 14
  • Go to the next page

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept